Does Vitamin B6 Reduce Inflammation?

Vitamin B6 keeps turning up in inflammation research, and at first glance the pattern looks like a smoking gun: the more inflamed a person is, the lower their vitamin B6 tends to be. That relationship is unusually strong and unusually reproducible across very different populations, from healthy community-dwellers to people with heart disease and rheumatoid arthritis. It is tempting to conclude that topping up B6 will bring inflammation down. The trial evidence, though, tells a more careful story, and understanding why is the key to using B6 sensibly.

Does Vitamin B6 Actually Lower Inflammation?

The most accurate answer is that vitamin B6 status and inflammation are locked together, but supplementing B6 has not reliably reduced inflammation in people who start with adequate levels. This is a classic case where a strong association does not translate into a treatment effect. Observational studies show that people with low B6 have more inflammation. Randomized trials that give people extra B6 rarely show their CRP falling as a result. Both things can be true at once, and the reconciling explanation is that the low B6 is often a consequence of the inflammation, not its cause.

The distinction matters practically. If low B6 caused inflammation, a supplement would be an obvious lever. If inflammation instead burns through B6, then the meaningful intervention is addressing whatever is driving the inflammation, while making sure your intake is adequate so a deficiency does not compound the problem. The current weight of evidence sits closer to the second interpretation, though B6 almost certainly plays some active role in inflammatory pathways too.

The Strong Link Between Low B6 and High CRP

The association itself is not in doubt. In a classic analysis of the Framingham Heart Study cohort, adults with elevated CRP had a mean plasma PLP of just 36.5 nmol/L compared with 55.8 nmol/L in those with normal CRP, and the link held even after adjusting for homocysteine, a related risk factor. In other words, the more inflamed group had roughly a third less circulating B6.

This is not a one-cohort fluke. A larger community-based study of 2,229 U.S. adults built a composite inflammation score from 13 markers and found geometric mean PLP of 61 nmol/L in the most inflamed third versus 80 nmol/L in the least inflamed third, a highly significant trend that persisted after accounting for how much B6 people actually ate. The relationship spanned acute-phase reactants, cytokines, adhesion molecules, and oxidative stress markers, which is why researchers describe inflammation as producing a functional B6 deficiency.

Similar inverse patterns show up in people with cardiovascular disease, rheumatoid arthritis, inflammatory bowel disease, and diabetes. The consistency across these very different conditions is exactly what makes B6 such an intriguing, and initially misleading, marker.

Why Supplementing B6 Usually Does Not Lower CRP

When researchers put the causal question to a direct test, the anti-inflammatory story tends to fall apart. In a double-blind, placebo-controlled trial in people with rheumatoid arthritis, 50 mg of pyridoxine daily for 30 days successfully corrected their vitamin B6 deficiency, yet it did not reduce production of the pro-inflammatory cytokines TNF-alpha or IL-6. The vitamin went up, the inflammation stayed put.

Cardiovascular trials point the same way. In the VITATOPS substudy of people with previous stroke or transient ischemic attack, a regimen of folic acid, vitamin B12, and 25 mg of vitamin B6 lowered homocysteine by 3.7 micromol/L but produced no significant change in high-sensitivity CRP, IL-6, or other inflammatory and endothelial markers. Reducing a related risk factor did not budge inflammation.

The chicken-and-egg logic. Put these findings next to the powerful observational associations and a coherent picture emerges. If B6 supplements reliably corrected inflammation, the trials would show it, and they do not. What fits the data better is that an active inflammatory process consumes or redistributes B6, pulling blood levels down. The low reading is then a footprint of inflammation rather than its origin. That is also why B6 can look like a promising target in cross-sectional data yet disappoint in a randomized trial.

How Common Is Low Vitamin B6?

Frank vitamin B6 deficiency is rare in countries with fortified food supplies, but mild inadequacy is not. Researchers estimate that mild B6 inadequacy, defined as plasma PLP below 20 nmol/L, affects roughly 19 to 27 percent of the U.S. population. Certain groups are more exposed: older adults, people with inflammatory or autoimmune conditions, heavy drinkers, and those with poor overall diet quality.

The biphasic wrinkle. B6 is not a case where more is always better. In animal models of colitis, both low B6 and high supplemental B6 suppressed molecular and histological markers of inflammation, hinting at a U-shaped or biphasic relationship rather than a simple straight line. This is one more reason to think of B6 in terms of sufficiency rather than as a dial you turn up to fight inflammation.

How Vitamin B6 Works in the Body

Vitamin B6 earns its central role because its active form, pyridoxal-5-phosphate, is a cofactor for more than 140 enzymatic reactions, including many in amino acid metabolism. Two of these pathways connect B6 directly to inflammation.

The tryptophan-kynurenine pathway. Several PLP-dependent enzymes sit along the kynurenine pathway, which the immune system ramps up during inflammation. When B6 is scarce, the pathway backs up and produces metabolites such as 3-hydroxykynurenine that themselves track with inflammatory markers. Studies of cardiovascular patients found that low PLP shifted this pathway in ways that reflected impaired tissue-level B6 status during inflammation, which is one proposed mechanism for why blood B6 falls when inflammation rises.

Sphingosine-1-phosphate and immune signaling. PLP is also required to break down sphingosine-1-phosphate, a lipid messenger that helps direct immune cells to sites of inflammation. This link between a B6-dependent enzyme and an immune-trafficking molecule is part of why B6 and inflammation are so mechanistically intertwined, even if supplementing the vitamin does not straightforwardly quiet the process.

Food Sources of Vitamin B6

For most people, meeting B6 needs through food is straightforward and carries none of the risks of high-dose supplements. Rich, everyday sources include:

• Fish and poultry: salmon, tuna, and chicken are among the most concentrated sources.
• Chickpeas and other legumes: a cup of chickpeas supplies a large share of the daily requirement.
• Starchy vegetables: potatoes and sweet potatoes are reliable contributors.
• Fruit: bananas are a well-known source, along with fortified cereals.
• Nuts and seeds: pistachios and sunflower seeds add meaningful amounts.

A varied diet built around these foods generally keeps PLP in a healthy range, which is the goal that the evidence actually supports.

Should You Take a B6 Supplement for Inflammation?

Based on the current evidence, taking high-dose vitamin B6 specifically to lower inflammation is not well supported. The more defensible approach is to make sure your intake is adequate, primarily through food, and to treat a low B6 reading as a possible signal that an inflammatory process is present and worth understanding rather than as a problem to fix with a pill.

A genuine safety ceiling. B6 is one of the few water-soluble vitamins with a well-documented toxicity: chronically high intakes, generally well above 100 mg per day and sometimes lower with long-term use, can cause sensory peripheral neuropathy, with numbness and tingling in the hands and feet. The tolerable upper intake level for adults is set at 100 mg per day. This is a real reason not to megadose B6 casually in pursuit of an anti-inflammatory benefit the trials have not confirmed. If you are considering supplementation, especially at doses above the recommended intake, discuss it with a healthcare provider.

Tracking Inflammation Instead of Chasing a Single Nutrient

The B6 story is a useful reminder that inflammation is a system, not a single deficiency. Because low B6 so often reflects an active inflammatory process, the more informative question is usually not whether one nutrient is low but whether your overall inflammatory load is trending up or down over time. CRP is the most practical marker for that, since it responds within days to weeks to changes in diet, sleep, activity, and stress. Sensa is a general wellness product that lets you measure CRP at home and watch the trend, so instead of guessing whether a supplement is helping, you can see whether your baseline is actually moving. CRP is a wellness insight rather than a diagnosis, so persistent elevations are worth discussing with a healthcare provider. To understand what the numbers mean, see our guide to understanding your CRP and normal CRP levels.

Sources

• Friso S, et al. Low Circulating Vitamin B6 Is Associated With Elevation of the Inflammation Marker C-Reactive Protein Independently of Plasma Homocysteine Levels (Circulation, 2001): pubmed.ncbi.nlm.nih.gov
• Sakakeeny L, et al. Plasma Pyridoxal-5-Phosphate Is Inversely Associated with Systemic Markers of Inflammation in a Population of U.S. Adults (Journal of Nutrition, 2012): pubmed.ncbi.nlm.nih.gov
• Selhub J, et al. Dietary vitamin B6 intake modulates colonic inflammation in the IL10-/- model of inflammatory bowel disease (Journal of Nutritional Biochemistry, 2013): pubmed.ncbi.nlm.nih.gov
• Chiang EI, et al. Pyridoxine supplementation corrects vitamin B6 deficiency but does not improve inflammation in patients with rheumatoid arthritis (Arthritis Research & Therapy, 2005): pubmed.ncbi.nlm.nih.gov
• Dusitanond P, et al. Homocysteine-Lowering Treatment With Folic Acid, Cobalamin, and Pyridoxine Does Not Reduce Blood Markers of Inflammation, Endothelial Dysfunction, or Hypercoagulability (VITATOPS substudy, Stroke, 2004): pubmed.ncbi.nlm.nih.gov

Frequently Asked Questions

Does vitamin B6 reduce inflammation?

Not directly, based on current evidence. Low vitamin B6 is strongly and consistently associated with higher CRP and other inflammatory markers, but randomized trials that supplement B6 usually do not lower CRP in people who are not deficient. The likeliest explanation is that inflammation depletes B6, so a low level reflects inflammation rather than causing it.

Why is vitamin B6 low when inflammation is high?

An active inflammatory process appears to increase the body's use and redistribution of vitamin B6, pulling blood levels of its active form (PLP) down. B6-dependent pathways such as tryptophan-kynurenine metabolism become more active during inflammation, which is one proposed reason PLP falls when markers like CRP rise.

How much vitamin B6 is safe to take?

The tolerable upper intake level for adults is 100 mg per day. Chronically high intakes, generally well above that and sometimes lower with long-term use, can cause sensory peripheral neuropathy with numbness and tingling in the hands and feet. Meeting B6 needs through food avoids this risk, and high-dose supplements should be discussed with a healthcare provider.

What foods are high in vitamin B6?

Concentrated sources include fish such as salmon and tuna, poultry, chickpeas and other legumes, potatoes and sweet potatoes, bananas, fortified cereals, and nuts and seeds like pistachios and sunflower seeds. A varied diet built around these foods generally keeps vitamin B6 in a healthy range.